Identifier |
20170403_nanos_sciplatform1_01-abstract |
Title |
Tocilizumab in Patients With Giant Cell Arteritis: Results From a Phase 3 Randomized Controlled Trial (abstract) |
Creator |
Susan Mollan, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Neil Collinson, John Stone |
Subject |
Vascular disorders, Neuro-ophth & systyemic disease ( eg. MS, MG, thyroid), Optic neuropathy |
Description |
The efficacy and safety of tocilizumab (TCZ), an IL-6 receptor-alpha inhibitor, was evaluated in patients with giant cell arteritis (GCA) in GiACTA, a randomized, double-blind, placebo-controlled trial.1 Data for week 52 outcome measures are presented. |
Date |
2017 |
Language |
eng |
Format |
application/pdf |
Source |
2017 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS Annual Meeting 2017: Scientific Platform I |
Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
Rights Management |
Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s67x067m |
Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
Contributor Primary |
Susan Mollan |
Contributor Secondary |
Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Neil Collinson, John Stone |
Setname |
ehsl_novel_nam |
ID |
1273002 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s67x067m |